FIELD: medicine.
SUBSTANCE: invention covers creation of an X-ray visible drug delivery device for subcutaneous introduction of a contraceptive or hormone replacement therapy, containing one branch consisting of (i) a kernel of thermoplastic polymer loaded with (a) contraceptive effective or therapeutically effective amount of desogestrel or 3-ketodesogestrel, and (b) approximately 4-30 wt % of X-ray contrast material, and (ii) coatings of thermoplastic polymer, covering the kernel and not containing a drug.
EFFECT: enhanced performance of the device.
13 cl, 11 ex, 6 tbl, 16 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| SYSTEM OF MEDICATION DELIVERY | 2008 |
|
RU2488369C2 |
| DRUG DELIVERY SYSTEM FOR DELIVERY OF ANTIVIRAL DRUGS | 2017 |
|
RU2755130C2 |
| SCHEME FOR GESTAGEN-ANTIGESTAGEN INTAKE | 1998 |
|
RU2215540C2 |
| SYSTEM OF DELIVERY OF MEDICINAL SUBSTANCE | 2004 |
|
RU2340344C2 |
| ULTRASOUND DETECTED INTRAUTERINE SYSTEM AND METHOD FOR ULTRASONIC DETECTION ENHANCEMENT | 2006 |
|
RU2389451C2 |
| INTRAUTERINE CARRIER | 2008 |
|
RU2503431C2 |
| INTRAUTERINE SYSTEM FOR THERAPEUTIC APPLICATION | 2010 |
|
RU2529477C2 |
| INTRAVAGINAL DRUG DELIVERY DEVICE | 2011 |
|
RU2648827C2 |
| METHOD FOR TREATMENT OF PROSTATE GLAND DISEASES BASED ON LOCAL DELIVERY OF ACTIVE MATERIALS | 2006 |
|
RU2404747C2 |
| METHOD OF SOLIDIFICATION USING ANTI-SOLVENT | 2004 |
|
RU2339364C2 |
